Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma

Leukemia

Volumn 23, Issue 11, 2009, Pages 2177-2181

  Roussou, M ^a   Tasidou, A ^b   Dimopoulos, M A ^a   Kastritis, E ^a   Migkou, M ^a   Christoulas, D ^a   Gavriatopoulou, M ^a   Zagouri, F ^a   Matsouka, C ^a   Anagnostou, D ^b   Terpos, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; STEROID; THALIDOMIDE; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4;

ANGIOGENESIS; ARTICLE; BONE DESTRUCTION; BONE DISEASE; BONE MARROW BIOPSY; CANCER SURVIVAL; DISEASE SEVERITY; HUMAN; IMMUNOREACTIVITY; MULTIPLE MYELOMA; MYELOMA; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVERALL SURVIVAL; PLASMA CELL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

AGED; BIOPSY; BONE DISEASES; CHEMOKINE CCL3; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; SEVERITY OF ILLNESS INDEX; TREPHINING;

EID: 70450245348     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.130     Document Type: Article

References (8)

1. Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD. Macrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 2001; 97: 3349-3353.
2. Terpos E, Politou M, Szydlo R, Goldman JM, Apperley JF, Rahemtulla A. Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma. Br J Haematol 2003; 123: 106-109.
3. Haaber J, Abildgaard N, Knudsen LM, Dahl IM, Lodahl M, Thomassen M et al. Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. Br J Haematol 2008; 140: 25-35.
4. Chen H, Campbell RA, Chang Y, Li M, Wang CS, Li J et al. Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: A novel mechanism of tumor-induced vasculogenesis. Blood 2009; 113: 1992-2002.
5. Padró T, Ruiz S, Bieker R, Bürger H, Steins M, Kienast J et al Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-2644.
6. Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F et al. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol 2003; 120: 53-55.
7. Abe M, Hiura K, Ozaki S, Kido S, Matsumoto T. Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production. J Bone Miner Metab 2009; 27: 16-23.
8. Choi SJ, Oba Y, Gazitt Y, Alsina M, Cruz J, Anderson J et al. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 2001; 108: 1833-1841.